Status | Study |
RECRUITING |
Study Name: Predictive Model for Prognosis of Chronic HBV Infection Mothers Condition: Hepatitis B, Chronic Date: 2021-03-17 Interventions: Exposure factors: Age, BMI, Family history, Baseline HBV DNA, Baseline HBeAg level, Baseline HBsAg level, Antiviral treatment, Serum ALT level |
Completed |
Study Name: Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B Condition: Hepatitis B, Chronic Date: 2016-03-18 Interventions: Drug: REP 2139-Ca the nucleic |
Enrolling by invitation |
Study Name: Use of TDF in Patients With Inactive Chronic Hepatitis B Infection Condition: Hepatitis B, Chronic Date: 2015-11-03 Interventions: Drug: Tenofovir disoproxil fumarate 300 mg, oral, once a day |
No longer available |
Study Name: Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients Condition: Hepatitis B, Chronic Date: 2014-12-23 Interventions: Drug: Emtricitabine emtricitabine were given to each patients for 48 weeks |
Not yet recruiting |
Study Name: Emtricitabine for Naive Chinese Chronic Hepatitis B Patients Condition: Hepatitis B, Chronic Date: 2014-12-23 Interventions: Drug: Emtricitabine emtricitabine were given to each patients at baseline and respoonse guided therapy w |
Active, not recruiting |
Study Name: Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis Condition: Hepatitis B, Chronic Date: 2014-08-21 Interventions: Drug: Tenofovir disoproxil fumarate White, almond-shaped, film-coated tablet containing 300 mg of TDF, d |
Active, not recruiting |
Study Name: Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study Condition: Hepatitis B, Chronic Date: 2014-07-17 Interventions: Drug: Tenofovir disoproxil fumarate Tenofovir disoproxil fumarate tablets supplied will be white, almond |
Completed |
Study Name: Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B Condition: Hepatitis B, Chronic Date: 2014-02-27 Interventions: Drug: Adefovir dipivoxil or Entecavir Adefovir tablet, 10m |
Completed |
Study Name: Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue Condition: Hepatitis B, Chronic Date: 2011-11-23 Interventions: Drug: GSK548470 300 mg tablet |
Completed |
Study Name: Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs Condition: Hepatitis B, Chronic Date: 2011-11-17 Interventions: Drug: GSK548470 300 mg tablet Blue tablets containing 300 mg of tenofovir disoproxil fumarate |